Connective tissue growth factor-mediated angiotensin II-induced hypertrophy of proximal tubular cells

Nephron - Experimental Nephrology

Volumn 103, Issue 1, 2006, Pages

  Liu, Bi Cheng ^a   Chen, Long ^a   Sun, Jing ^a   Huang, Hai Quan ^a   Ma, Kun Ling ^a   Liu, Hong ^a   Liu, Dian Ge ^a   Zhang, Xiao Liang ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Angiotensin II; Connective tissue growth factor; Hypertrophy; Renal tubular cell

Indexed keywords

ANGIOTENSIN II; ANTISENSE OLIGODEOXYNUCLEOTIDE; CONNECTIVE TISSUE GROWTH FACTOR; IRBESARTAN; MESSENGER RNA;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL CYCLE G1 PHASE; CELL HYPERPLASIA; CELL SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; FLOW CYTOMETRY; GLOMERULAR STRUCTURE; IMMUNOHISTOCHEMISTRY; KIDNEY HYPERTROPHY; KIDNEY MASS; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RANDOMIZATION; RAT; SCANNING ELECTRON MICROSCOPE; STAINING;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIPHENYL COMPOUNDS; CELL CYCLE; CELL LINE; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; HYPERTROPHY; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRAZOLES;

EID: 33646005773     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090504     Document Type: Article

References (31)

1. Fine LG: The biology of renal hypertrophy. Kidney Int 1986;29:619-634.
2. Wolf G: Vasoactive factors and tubulointerstitial injury. Kidney Blood Press Res 1999;22:62-70.
3. Hannken T, Schroeder R, Stahl RAK, Wolf G: Atrial natriuretic peptide attenuates AngII-induced hypertrophy of renal tubular cells. Am J Physiol 2001;281:F81-F90.
4. Kennefick TM, Anderson S: Role of angiotensin II in diabetic nephropathy. Semin Nephrol 1997;17:441-447.
5. Guo DF, Tardif V, Ghelima K: A novel angiotensin II type 1 receptor-associated protein induces cellular hypertrophy in rat vascular smooth muscle and renal proximal tubular cells. J Biol Chem 2004;279:21109-21120.
6. Mezzano SA, Ruiz-Ortega M, Egido J: Angiotensin II and renal fibrosis. Hypertension 2001;38:635-638.
7. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J: Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001;10:321-329.
8. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993;3:1531-1540.
9. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998;53:853-861.
10. Ito Y, Goldschmeding R, Bende R, Claessen N, Chand M, Kleij L, Rabelink T, Weening J, Aten J: Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. J Am Soc Nephrol 2001;12:472-484.
11. Ziyaheh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993;22:736-744.
12. Hishikawa K, Oemar BS, Nakaki T: Static pressure regulates connective tissue growth factor expression in human mesangial cells. J Biol Chem 2001;276:16797-16803.
13. Wolf G, Ziyadeh FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999;56:393-405.
14. Kriz W: Progressive renal failure-inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 1996;11:1738-1742.
15. Wolf G, Neilson EG: Morphogenic cues that modulate podocyte growth. Kidney Int 1998;53:1087-1088.
16. Pagtalunan ME, Miller PL, Jumping-Eagle S, Neilson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type 2 diabetes. J Clin Invest 1997;99:342-348.
17. Zhang SL, Filep JG, Hohman TC: Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int 1999;55:454-464.
18. Gross ML, El-Shakmak A, Szabo A: ACE inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia 2003;46:856-868.
19. Wolf G, Jablonski K, Schroeder R: Angiotensin II-induced hypertrophy of proximal tubular cells requires p27Kip1. Kidney Int 2003;64:71-81.
20. Wolf G, Wenzel U, Ziyadeh FN, Stahl RA: Angiotensin converting-enzyme inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats. Diabetologia 1999;42:1425-1432.
21. Grotendorst GR: Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev 1997;8: 171-179.
22. Bradham DM, Igarashi A, Potter RL, Grotendorst GR: Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991;114:1285-1294.
23. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR: Suppression subtractive hybridization identifies high glucose level as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999;274:5830-5834.
24. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, Marins RG: Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 2000;11:25-38.
25. Yokoi H, Sugawara A, Mokoyama M, Mori K, Makino H, Suganami T, Nagae T, Yahata K, Fujinaga Y, Tanaka T, Nakao K: Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: a potential target for preventing renal fibrosis. Am J Kidney Dis 2001;38:s134-s138.
26. Abdel-Wahab N, Mason RM: Connective tissue growth factor and renal diseases: some answers, more questions. Curr Opin Nephrol Hypertens 2004;13:53-58.
27. Yokoi H, Mukoyama M, Nagae T: Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 2004;15:1430-1440.
28. Abdel-Wahab N, Weston BS, Roberts T, Mason RM: Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J Am Soc Nephrol 2002;13:2437-2445.
29. Ruperez M, Ruiz-Ortega M, Esteban V: Angiotensin II increases connective tissue growth factor in the kidney. Am J Pathol 2003;163:1937-1947.
30. Andersen S, van Nieuwenhoven FA, Tarnow L, Rossing P, Rossing K, Wieten L, Goldschmeding R, Parving HH: Reduction of urinary connective tissue growth factor by losartan in type 1 patients with diabetic nephropathy. Kidney Int 2005;67:2325-2329.
31. Van Nieuwenhoven FA, Rossing K, Andersen S: Beneficial effect of dual blockade of the renin-angiotensin system on urinary connective tissue growth factor in type 2 diabetic patients with nephropathy. J Am Soc Nephrol 2004;15:571A.